openPR Logo
Press release

Testosterone Replacement Therapy (TRT) Market To Face Lean Patch Until 2024 As It Inches Close To Patent Cliff

03-30-2017 02:13 PM CET | Health & Medicine

Press release from: Transparecny Market Research

Testosterone Replacement Therapy (TRT) Market To Face Lean

AbbVie, Inc. emerged the undisputed leader in a highly consolidated global testosterone replacement therapy (TRT) market in 2015 thanks to its star performer TRT product, AndroGel, finds Transparency Market Research (TMR) in a new study. Endo Pharmaceuticals, Inc., Eli Lilly and Company, Allergan plc, and Bayer AG are the other strong contenders in this space. The top five players together held sway over 80% of the market in the same year, finds TMR.

Obtain Report Details @ http://www.transparencymarketresearch.com/testosterone-replacement-therapy.html

Although in the short term, the advent of innovative testosterone replacement therapy technology such as spray-on and unmodified testosterone will give the testosterone market a shot in the arm, the market is nearing a patent cliff. As a result of these imminent patent expirations, the market will witness a decline in revenues. “Yet, it’s a not entirely a bleak picture. With several drivers acting upon the market, slow albeit steady growth will be possible. There is a rising demand for advanced TRT products as consumers become more aware about the options available to them,” says a TMR analyst.

Increased Prevalence of Testosterone Deficiency will Augur well for TRT Market

Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.

At the same time, the report states that the geriatric population, which is rising at a steady pace worldwide, represents a massive target demographic for companies in the TRT market. The number of men reporting a deficiency in testosterone levels is likely to rise as the number of aged individuals soars worldwide. Overall, the effect of these two drivers will be compounded by an overall increase in the awareness levels about testosterone replacement therapy (TRT).

Perceived Risk of TRT Side Effects to Weaken Efforts of Key Players

The perceived risk of cardiovascular or metabolic disease associated with treating testosterone deficiency has hampered the consumption of TRT products. Moreover, with numerous studies evidencing the adverse effects, the FDA has issued adequate warnings pertaining to these risks, causing many patients to view TRT in a negative light. “Although these risks are associated only with certain TRT products, this is perhaps the greatest challenge that companies in the TRT market will have to overcome,” opines a TMR analyst.

According to TMR, the other challenge that stands in the way of the market’s growth is the expiry of key TRT products, which will clear the path for the entry of generics. The three top performers in the testosterone replacement therapy market currently are AbbVie, Inc.’s AndroGel, Eli Lilly and Company’s Axiron, and Endo Pharmaceuticals, Inc.’s Nebido. While AndroGel’s patent expired in 2015, Axiron and Nebido are heading toward a patent expiry, which will deal a blow to the revenues of the top market players.

Global Testosterone Replacement Therapy Market to Witness Sizeable Decline in Revenues

According to Transparency Market Research, testosterone replacement therapy revenues will reach US$1.3 bn globally in 2024, down noticeably from US$2.0 bn in 2015. This translates to a (-4.2)% CAGR for the market from 2016 to 2024.

By type, the global TRT products market was dominated by creams and gels in 2015, which accounted for nearly 66% of the market worldwide. The fastest growth will be observed in the injections product segment through the forecast period of TMR’s study.

Fill The Form To Gain Deeper Insights On This Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1097

Among all the major active ingredients available on the market, testosterone in its native form was observed to be the leading segment with over 68% of the global TRT market. Likewise, the North America TRT market stood as the largest worldwide in 2015 with an 84.7% share. It was trailed by Europe and Asia Pacific, in that order.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Testosterone Replacement Therapy (TRT) Market To Face Lean Patch Until 2024 As It Inches Close To Patent Cliff here

News-ID: 486321 • Views: 237

More Releases from Transparecny Market Research

Fly Ash Market Estimated to Reach Us$ 11,371 Mn By 2026
According to a new report published by Transparency Market Research (TMR) titled 'Fly Ash Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026,' the global fly ash market is estimated to reach US$ 11,371.0 Mn by 2026 and is anticipated to expand at a CAGR of 7.1% during the forecast period. Expansion in the global fly ash market is primarily driven by the growth in end-user industries
Carbon Fiber Market to Reap Voluminous Revenues As Automotive Industry Focuses o …
The demand within the global carbon fiber market has been rising on account of advancements in the domain of chemical research and testing, finds Transparency Market Research. The presence of a stellar industry for studying the properties of carbon-based materials has led to the growth of this market. The heavy reliance of the textiles industry on the supply woven carbon filaments has also played a crucial role in accelerating market
Global Enzymes Market to Reach a Valuation Of ~Us$ 12.2 Bn by 2027
Key Highlights: The global enzymes market was valued at approximately ~US$ 6.4 Bn in 2018 and is anticipated to expand at a CAGR of more than 7% from 2019 to 2027 Rise in demand for enzymes for use in the food & beverages processing application is driving the global enzymes market. North America accounted for a major share of the global enzymes market in 2018. Get Research Report Overview @ https://www.transparencymarketresearch.com/enzymes-market.html In terms of demand,
Global Propane Market to Witness 5% CAGR From 2019 to 2027
As per a recent report by Transparency Market Research, the global propane market is expected to experience a consistent growth over the period of 2019 to 2027. The report mentions the facts that due to widespread application of propane in numerous petrochemical industries, the market shall witness 5% CAGR in the mentioned period of 2019 to 2027. Moreover, post analysis of the market, the experts at Transparency Market Research states

All 5 Releases


More Releases for TRT

Patent Expiry Blow Dealt to TRT Market Could be Softened by Growing Prevalence o …
A wide range of testosterone replacement therapy (TRT) products containing different active ingredients have been made available by a large number of both global and local manufacturers. With various studies estimating the number of men affected by hypogonadism (testosterone deficiency) at 30% worldwide, the demand for TRT is poised to increase gradually in the years ahead. The condition primarily affects men aged between 40 and 79 years, making this demographic
Testosterone Replacement Therapy Market: TRT Creams and Gels Continue to See Str …
Some of the key players in the global testosterone replacement therapy market include names such as Allergan Plc., AbbVie Inc., Bayer AG., Eli Lilly and Company, Endo Pharmaceuticals, Kyowa Kirin International Plc., Novartis AG., Mylan N.V., and Pfizer Inc. among others. The global market for testosterone replacement therapy is a little bit consolidate with the existence of a few big established companies and the presence of some domestic vendors that
Testosterone Replacement Therapy Market: Increased Prevalence of Testosterone De …
A wide range of testosterone replacement therapy (TRT) products containing different active ingredients have been made available by a large number of both global and local manufacturers. With various studies estimating the number of men affected by hypogonadism (testosterone deficiency) at 30% worldwide, the demand for TRT is poised to increase gradually in the years ahead. The condition primarily affects men aged between 40 and 79 years, making this demographic
01-10-2017 | Health & Medicine
TMR
Testosterone Replacement Therapy (TRT) Market to Face Lean Patch until 2024 as i …
A wide range of testosterone replacement therapy (TRT) products containing different active ingredients have been made available by a large number of both global and local manufacturers. With various studies estimating the number of men affected by hypogonadism (testosterone deficiency) at 30% worldwide, the demand for TRT is poised to increase gradually in the years ahead. The condition primarily affects men aged between 40 and 79 years, making this demographic
Men's Health Therapeutics Market: Introduction of gel formulations for testoster …
Men’s health therapeutics are used for males to treat and correct the diseases and disorders specific to androgens. Such therapeutics have garnered attention in recent times because of the health problems as a result of changes in hormones level.A rise in average age of men is observed globally which further results into increase in number of males with declined testosterone levels. The declined level of this hormone is major cause
Testosterone Replacement Therapy (TRT) Market to Face Lean Patch until 2024 as i …
AbbVie, Inc. emerged the undisputed leader in a highly consolidated global testosterone replacement therapy (TRT) market in 2015 thanks to its star performer TRT product, AndroGel, finds Transparency Market Research (TMR) in a new study. Endo Pharmaceuticals, Inc., Eli Lilly and Company, Allergan plc, and Bayer AG are the other strong contenders in this space. The top five players together held sway over 80% of the market in the same